Work

The prognostic significance of stable disease following high-dose interleukin-2 (IL-2) treatment in patients with metastatic melanoma and renal cell carcinoma

Year: 2015

Type: article

Study design: Observational Study

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s00262-014-1652-6

Authors: Tasha Hughes, Matthew Klairmont, Joseph Broucek, Gail Iodice, Sanjib Basu, Howard L. Kaufman

Institutions: Rush University, Columbia University, Rutgers Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis (U01), Cancer Center Support Grant

OpenAlex ID: W1965437294

FWCI: 2.62

Cites: 23

Cited by: 36

Related to: 10